Deconstructing the Master Switch: Advances in Direct NLRP3 Inhibition. [PDF]
Xu Y, Murphy S.
europepmc +1 more source
Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure. [PDF]
Catanese B +3 more
europepmc +1 more source
KCNJ11-associated infantile epileptic spasms syndrome and neonatal diabetes. [PDF]
Gonzalez BJ +9 more
europepmc +1 more source
A nomogram integrating machine learning with clinical predictors for osteosarcopenia risk prediction in type 2 diabetes mellitus. [PDF]
Liang D, Zhan Z, Zhang Y, Yan S.
europepmc +1 more source
Comparative safety of sulfonylurea therapies on cardiovascular and severe hypoglycemia outcomes among adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation. [PDF]
Sklepinski S +15 more
europepmc +1 more source
GLP-1 Receptor Agonists and All-Cause Overdose Risk in Veterans With Type 2 Diabetes and Opioid Use Disorder. [PDF]
Kennedy KP +6 more
europepmc +1 more source
Inhibition Mechanism of Pancreatic K<sub>ATP</sub> Channels by Centipede Toxin. [PDF]
Hou T, Wang M, Tan Y, Fan C, Chen L.
europepmc +1 more source
An Interesting Case of Sulphonylurea-Responsive Permanent Neonatal Diabetes Mellitus With Potassium Channel Mutation. [PDF]
O'Connell K +3 more
europepmc +1 more source
Real-world treatment patterns and adherence among privately insured patients with type 2 diabetes in Saudi Arabia: a retrospective cohort study using national claims data. [PDF]
Alghamdi S +8 more
europepmc +1 more source
Integrative GC-MS, FT-IR, and Molecular Docking Analysis of <i>Drimycarpus racemosus</i> (Roxb.) Hook.f ex Marchand: In Vivo Analgesic and Antidiabetic Potential. [PDF]
Ali MS +7 more
europepmc +1 more source

